
@ShahidNShah
Previously, we contemplated the practical opportunities of the assistance of artificial intelligence (AI) technologies in clinical trials for drug development. Such assistance extends before and after trials commence, and in this article, we will focus on the pre-clinical trial aspect.
In particular, we will focus on the drug discovery stage which involves the identification and creation of new medications. This process has, traditionally, been a time-consuming and labour-intensive one. In the age of AI, drug discovery can be made more efficient and precise. We will take a look at how this can be the case in this article.
Continue reading at medicalfuturist.com
The chair of clinical pharmacy practice details how the organization got, for example, racial/ethnic minorities receiving chemotherapy two times higher likelihood in reporting pain compared with …
Posted Sep 12, 2024 PCM (Patient Care Management) #CancerChat
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Feb 21, 2025 at 1:11pm